Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2461 AL 2475

Hemichorea in a thymoma patient without anti-CRMP-5 antibody

Nakae Y, Ikeda S, Yamamoto R, Tanaka F, Johkura K.

Neurol Sci. 2014 Apr;35(4):629-30. doi: 10.1007/s10072-014-1629-4. Epub 2014 Jan 11.

Early motor deficits in mouse disease models are reliably uncovered using an automated home-cage wheel-running system: a cross-laboratory validation

Mandillo S, Heise I, Garbugino L, Tocchini-Valentini GP, Giuliani A, Wells S, Nolan PM.

Dis Model Mech. 2014 Mar;7(3):397-407. doi: 10.1242/dmm.013946. Epub 2014 Jan 13.

Diagnostic criteria of acute rheumatic fever

Burke RJ, Chang C.

Autoimmun Rev. 2014 Apr-May;13(4-5):503-7. doi: 10.1016/j.autrev.2014.01.036. Epub 2014 Jan 11.

The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?

Gil-Mohapel J, Brocardo PS, Christie BR.

Curr Drug Targets. 2014 Apr;15(4):454-68. doi: 10.2174/1389450115666140115113734.

The ubiquitin-proteasome system in neurodegeneration

McKinnon C, Tabrizi SJ.

Antioxid Redox Signal. 2014 Dec 10;21(17):2302-21. doi: 10.1089/ars.2013.5802. Epub 2014 Feb 27.

First case with Huntington's disease in The Gambia

Almaguer-Mederos LE, Vega Abascal J, Ramos Cabrera A, García Quilez F, Betancourt Álvarez P, Miranda Rosales F, Ferriol Ramírez A, Khalil MI, de Jorge López L, Volpini V, Nyan O.

J Neurol Sci. 2014 Mar 15;338(1-2):238-40. doi: 10.1016/j.jns.2013.12.045. Epub 2014 Jan 7.

[Deep brain stimulation for hyperkinetic movement disorders]

Reich MM, Volkmann J.

Nervenarzt. 2014 Feb;85(2):147-55. doi: 10.1007/s00115-013-3877-6.

Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies

Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, Balanzá-Martínez V, Climent J, Valencia A, McGrath J, Crespo-Facorro B, Sanchez-Moreno J, Vieta E, Tabarés-Seisdedos R.

Psychother Psychosom. 2014;83(2):89-105. doi: 10.1159/000356498. Epub 2014 Jan 22.

Emotion perception and electrophysiological correlates in Huntington's disease

Croft RJ, McKernan F, Gray M, Churchyard A, Georgiou-Karistianis N.

Clin Neurophysiol. 2014 Aug;125(8):1618-25. doi: 10.1016/j.clinph.2013.12.111. Epub 2014 Jan 10.

Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases

Wyse RD, Dunbar GL, Rossignol J.

Int J Mol Sci. 2014 Jan 23;15(2):1719-45. doi: 10.3390/ijms15021719.

Neurological presentations of the antiphospholipid syndrome: three illustrative cases

De Maeseneire Ch, Duray MC, Rutgers MP, Gille M.

Acta Neurol Belg. 2014 Jun;114(2):117-23. doi: 10.1007/s13760-013-0275-6. Epub 2014 Jan 25.

[Chorea as a first sign of anti-phospholipid syndrome]

Gutiérrez Moreno M, Hortigüela Saeta M, Merino Arribas JM, Conejo Moreno D, Blanco Barrio A.

An Pediatr (Barc). 2014 Nov;81(5):338-40. doi: 10.1016/j.anpedi.2013.05.029. Epub 2014 Jan 25.

Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls

Jiang H, Sun YM, Hao Y, Yan YP, Chen K, Xin SH, Tang YP, Li XH, Jun T, Chen YY, Liu ZJ, Wang CR, Li H, Pei Z, Shang HF, Zhang BR, Gu WH, Wu ZY, Tang BS, Burgunder JM; Chinese HD Network.

Eur J Neurol. 2014 Apr;21(4):637-42. doi: 10.1111/ene.12366. Epub 2014 Jan 28.

Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease

Song J, Park KA, Lee WT, Lee JE.

Int J Mol Sci. 2014 Jan 29;15(2):2119-29. doi: 10.3390/ijms15022119.

Movement disorders in pregnancy

Miyasaki JM, Aldakheel A.

Continuum (Minneap Minn). 2014 Feb;20(1 Neurology of Pregnancy):148-61. doi: 10.1212/01.CON.0000443842.18063.a9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias